NCT07073378

Brief Summary

The goal of this trial is to evaluate use of brain computer interfaces (BCI) at home for children with severe severe physical disabilities. The main questions it aims to answer are:

  1. 1.Can a home BCI program enable children with disabilities to achieve personalized life participation goals?
  2. 2.Can a home BCI program promote implementation reach?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
16mo left

Started Nov 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Nov 2025Aug 2027

First Submitted

Initial submission to the registry

June 24, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

July 18, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

May 5, 2026

Status Verified

July 1, 2025

Enrollment Period

1.8 years

First QC Date

June 24, 2025

Last Update Submit

April 29, 2026

Conditions

Keywords

pediatric brain computer interface

Outcome Measures

Primary Outcomes (2)

  • Canadian Occupational Performance Measure

    The primary effectiveness outcome is achievement of child and family-identified participation-based goals, as measured by the Canadian Occupational Performance Measure (COPM). Participants/families will set 3-5 goals, and then score the Importance, Performance, and Satisfaction with each goal on a 1-10 scale.

    Baseline and end of treatment at 6 months

  • Implementation Reach

    The primary implementation outcome is the proportion of children recruited from equity-deserving groups. A baseline survey will capture comprehensive demographics.

    through study completion, an average of 2 years

Study Arms (1)

BCI at home

EXPERIMENTAL

Home BCI use. Families will first complete an in-person visit to review available activities, set their first goals, and learn to use BCI independently. A BCI "kit" will be given to each family, with a headset and the equipment and software required to pursue their identified goals. Following this, families will participate in 12 virtual sessions over 3-6 months. Scheduling will be flexible to accommodate complex family needs. Daily online support will be provided via a messaging application. Participants who choose to continue using BCI beyond 12 sessions will be provided kits and supported.

Device: Brain computer interface

Interventions

Families will first complete an in-person visit to review available activities, set their first goals, and learn to use BCI independently. A BCI "kit" will be given to each family, with a headset and the equipment and software required to pursue their identified goals. Following this, families will participate in 12 virtual sessions over 3-6 months. Scheduling will be flexible to accommodate complex family needs. Daily online support will be provided via a messaging application. Participants who choose to continue using BCI beyond 12 sessions will be provided kits and supported.

BCI at home

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 5-18 years
  • Severe motor impairment including inability to walk and minimal functional hand use, and/or;
  • Severe communication impairment
  • Ability to follow simple instructions and attend to simple tasks
  • Home environment suitable for the program based on clinician and family discussion;
  • Informed assent/consent

You may not qualify if:

  • Epileptic encephalopathy
  • Unstable epilepsy, or
  • Brain imaging incompatible with BCI functionality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Alberta Children's Hospital

Calgary, Alberta, Canada

RECRUITING

Glenrose Rehabilitation Hospital

Edmonton, Alberta, Canada

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyGenetic Diseases, InbornBrain Injuries

Interventions

Brain-Computer Interfaces

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Electrical Equipment and SuppliesEquipment and Supplies

Central Study Contacts

Central Contact Person

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Neurologist

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 18, 2025

Study Start

November 1, 2025

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

May 5, 2026

Record last verified: 2025-07

Locations